文档介绍：Published OnlineFirst October 13, 2009; DOI:--09-2099
Direct Evidence that Bevacizumab, an Anti-VEGF Antibody,
Up-regulates SDF1 α, CXCR4, CXCL6, and Neuropilin 1 in
Tumors from Patients with Rectal Cancer
Lei Xu, Dan G. Duda, Emmanuelle di Tomaso, et al.
Cancer Res 2009;69:7905-7910. Published OnlineFirst October 13, 2009.
Updated Version Access the most recent version of this article at:
doi:--09-2099
Cited Articles This article cites 19 articles, 7 of which you can access for free at:
http://cancerres./content/69/20/#ref-list-1
Citing Articles This article has been cited by 8 HighWire-hosted articles. Access the articles at:
http://cancerres./content/69/20/#related-urls
E-mail alerts Sign up to receive free email-alerts related to this article or journal.
Reprints and To order reprints of this article or to subscribe to the journal, contact the AACR
Subscriptions Publications Department at ******@.
Permissions To request permission to re-use all or part of this article, contact the AACR Publications
Department at ******@.
Downloaded from cancerres. on March 13, 2012
Copyright © 2009 American Association for Cancer Research
Published OnlineFirst October 13, 2009; DOI:--09-2099
Priority Report
Direct Evidence that